Aeterna Zentaris (AEZS) Announces DSMB Recommendation to Continue Phase 3 ZoptEC in Metastatic Endometrial Cancer
Tweet Send to a Friend
Aeterna Zentaris (NASDAQ: AEZS) announced that the independent Data and Safety Monitoring Board ("DSMB") has recommended that the pivotal Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
